Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
Top Cited Papers
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 269 (1) , 7-17
- https://doi.org/10.1016/j.canlet.2008.03.037
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregatesGenes & Development, 2007
- Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistanceBlood, 2007
- Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphomaJournal of Clinical Investigation, 2007
- Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cellsApoptosis, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*Breast Cancer Research and Treatment, 2005
- Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosisCell Death & Differentiation, 2005
- Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate CancerThe Prostate, 2004
- The Hallmarks of CancerCell, 2000